The aim of present study was to evaluate the antihyperglycemic and antihyperlipidemic effects of aerial parts of Rubus ulmifolius Schott on streptozotocin (STZ)-induced diabetic albino mice. A total of 48-, 60-day-old either sex (male and female) albino mice were treated with, normal control; 2% Tween-80 suspension (diabetic control); glibenclamide (500 μg/kg/orally); RU methanol extract (150 mg/kg/orally) (RUCrd1); RU methanol extract (300 mg/kg/orally) (RUCrd2); RU chloroform extract (150 mg/kg/orally) (RUC); RU ethyl acetate extract (150 mg/kg/orally) (RUE); and RU butanol extract (150 mg/kg/orally) (RUB) for a period of 15 days. Diabetes was induced in albino mice by single intraperitoneal injection of streptozotocin (50 mg/kg/b/w). After 15 days, group treated with glibenclamide, RUCrd1, RUCrd2, RUC, RUE and RUB exhibited a significant (P > 0.05) decrease in blood glucose level as compared to diabetic control groups. The total cholesterol, triglycerides and low-density lipoproteins as well as serum creatinine level, serum glutamate pyruvate transaminase, serum glutamate oxaloacetate transaminase and alkaline phosphatase were also significantly (P > 0.05) decreased in glibenclamide, RUCrd1, RUCrd2, RUC, RUE and RUB groups albino mice as compared to diabetic control. It was concluded that Rubus ulmifolius Schott extract has positive effect as hypoglycemic and antihyperlipidemic on diabetic albino mice.